Repurposing GLP-1 receptor agonists and SGLT-2 inhibitors in neurodegeneration and metabolically at-risk populations: Myth or reality? An overview of randomized clinical trials

Diabetes Research and Clinical Practice 2026

View at publisher
Authors: Michail-Angelos Mourtzos, Dimitrios Patoulias, Natalia-Maria Keklikoglou, Paschalis Karakasis, Valeria Gutierrez de Piñeres, Konstantinos Stefanakis, Manfredi Rizzo, Christos S. Mantzoros
DOI: 10.1016/j.diabres.2026.113345
Cited by: 1
References: 19

Fields of Study & Subjects

Diabetes Treatment and Management Regulation of Appetite and Obesity Metabolism Diabetes and Cancer

Publication details

Journal / source
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Volume
237
Pages
113345–113345
Publication date
27 May 2026
Language
EN